A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: Extended perspectives beyond resistance

American Journal of Infection Control

Volumn 38, Issue 10, 2010, Pages 839-845

  Berger, Jutta ^a   Diab Elschahawi, Magda ^a   Blacky, Alexander ^a   Pernicka, Elisabeth ^a   Spertini, Verena ^a   Assadian, Ojan ^a   Koller, Walter ^a   Aichberger, Karl J ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bacteremia; mortality; risk factor

Indexed keywords

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHRONIC LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIABETES MELLITUS; DISEASE ASSOCIATION; EMERGENCY PATIENT; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; INFECTION SENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEOPLASM; ORGAN TRANSPLANTATION; PERIPHERAL VASCULAR DISEASE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECONDARY INFECTION; SKIN DISEASE; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; UROGENITAL TRACT DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650221938     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.04.212     Document Type: Article

References (42)

1. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317
2. A.C. Fluit, M.E. Jones, F.J. Schmitz, J. Acar, R. Gupta, and J. Verhoef Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998 Clin Infect Dis 30 2000 454 460
3. B.E. Kreger, D.E. Craven, P.C. Carling, and W.R. McCabe Gram-negative bacteremia, III: Reassessment of etiology, epidemiology and ecology in 612 patients Am J Med 68 1980 332 343
4. J. Rodriguez-Baño, M.D. Navarro, L. Romero, M.A. Muniain, M. de Cueto, and M.J. Rios Bacteremia due to extended-spectrum beta-lactamase- producing Escherichia coli in the CTX-M era: a new clinical challenge Clin Infect Dis 43 2006 1407 1414
5. M.B. Edmond, S.E. Wallace, D.K. McClish, M.A. Pfaller, R.N. Jones, and R.P. Wenzel Nosocomial blood stream infections in United States hospitals: a three-year analysis Clin Infect Dis 29 1999 239 244
6. L.O. Conterno, S.B. Wey, and A. Castelo Risk factors for mortality in Staphylococcus aureus bacteremia Infect Control Hosp Epidemiol 19 1998 32 37
7. J. Vallés, J. Rello, A. Ochagavía, J. Garnacho, and M.A. Alcalá Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival Chest 123 2003 1615 1624
8. B. Olesen, H.J. Kolmos, F. Orskov, I. Orskov, and A. Gottschau Bacteraemia due to Escherichia coli in a Danish university hospital, 1986-1990 Scand J Infect Dis 27 1995 253 257
9. L.B. Johnson, M.O. Almoujahed, K. Ilg, L. Maolood, and R. Khatib Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse Scand J Infect Dis 35 2003 782 789
10. A. Schmid, H. Schneider, A. Adlof, K.H. Smolle, G. Edelmann, and P. Sporn Economic burden of illness by severe sepsis in Austria Wien Klin Wochenschr 114 2002 697 701 (Pubitemid 35033592)
11. T.A. Russo, and J.R. Johnson Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem Microbes Infect 5 2003 449 456
12. G.S. Gottlieb, V.G. Fowler Jr., L.K. Kong, R.S. McClelland, A.K. Gopal, and K.A. Marr Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility J Am Coll Surg 190 2000 50 57
13. C. Hawkins, J. Huang, G.A. Noskin, T.R. Zembower, and M. Bolon Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes Arch Int Med 167 2007 1861 1867
14. F.Y. Chang, B.B. MacDonald, J.E. Peacock Jr., D.M. Musher, P. Triplett, and J.M. Mylotte A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance Medicine (Baltimore) 82 2003 322 332
15. E.E. Hill, S. Vanderschueren, J. Verhaegen, P. Herijgers, P. Claus, and M.C. Herregods Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia Mayo Clin Proc 82 2007 1165 1169
16. W. Greiner, A. Rasch, D. Köhler, B. Salzberger, G. Fätkenheuer, and M. Leidig Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients Clin Microbiol Infect 13 2007 264 268
17. E. González-Barca, J. Carratalá, A. Mykietiuk, A. Fernández-Sevilla, and F. Gudiol Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer Eur J Clin Microbiol Infect Dis 20 2001 117 119
18. A.K. Gopal, V.G. Fowler Jr., M. Shah, D. Gesty-Palmer, K.A. Marr, and R.S. McClelland Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy J Clin Oncol 18 2000 1110 1115
19. G. Jacobsson, E. Gustafsson, and R. Andersson Outcome for invasive Staphylococcus aureus infections Eur J Clin Microbiol Infect Dis 27 2008 839 848
20. S.E. Cosgrove, G. Sakoulas, E.N. Perencevich, M.J. Schwaber, A.W. Karchmer, and Y. Carmeli Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clin Infect Dis 36 2003 53 59 (Pubitemid 36099097)
21. S.E. Cosgrove, Y. Qi, K.S. Kaye, S. Harbarth, A.W. Karchmer, and Y. Carmeli The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges Infect Control Hosp Epidemiol 26 2005 166 174
22. D.L. Paterson, and R.A. Bonomo Extended-spectrum beta-lactamases: a clinical update Clin Microbiol Rev 18 2005 657 686
23. R. Ramphal, and P.G. Ambrose Extended-spectrum beta-lactamases and clinical outcomes: current data Clin Infect Dis 42 2006 164 172
24. I.M. Gould The clinical significance of methicillin-resistant Staphylococcus aureus J Hosp Infect 61 2005 277 282
25. I.M. Gould MRSA bacteraemia Int J Antimicrob Agents 30 2007 66 70
26. F. Daxboeck, T. Budic, O. Assadian, M. Reich, and W. Koller Economic burden associated with multi-resistant gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital J Hosp Infect 62 2006 214 218
27. H.S. Cheong, C.I. Kang, K.T. Kwon, S.T. Heo, Y.M. Wi, and E.S. Kim Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia J Antimicrob Chemother 60 2007 1355 1360
28. L. DeOliveira Conterno, S.B. Wey, and A. Castelo Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality Braz J Infect Dis 6 2002 288 297
29. G. Faetkenheuer, M. Preuss, B. Salzberger, N. Schmeisser, O.A. Cornely, and H. Wisplinghoff Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia Eur J Clin Microbiol Infect Dis 23 2004 157 162
30. C. Kaech, L. Elzi, P. Sendi, R. Frei, G. Laifer, and S. Bassetti Course and outcome of Staphylococcus aureus bacteremia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre Clin Microbiol Infect 12 2006 345 352
31. O. Lyytikäinen, E. Ruotsalainen, A. Järvinen, V. Valtonen, and P. Ruutu Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001 Eur J Clin Microbiol Infect Dis 24 2005 399 404
32. F.D. Wang, Y.Y. Chen, T.L. Chen, and C.Y. Liu Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia Am J Infect Control 36 2008 118 122
33. P.C. Hill, M. Birch, S. Chambers, D. Drinkovic, R.B. Ellis-Pegler, and R. Everts Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality Intern Med J 31 2001 97 103
34. J.M. Mylotte, C. McDermott, and J.A. Spooner Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia Rev Infect Dis 9 1987 891 907
35. A.G. Jensen, C.H. Wachmann, K.B. Poulsen, F. Espersen, J. Scheibel, and P. Skinhøj Risk factors for hospital-acquired Staphylococcus aureus bacteremia Arch Intern Med 159 1999 1437 1444
36. J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, and J.M. Hughes CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 1988 128 140
37. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing, 15th international supplement. CLSI/NCCLS document M100-S15 2004 Clinical and Laboratory Standards Institute Wayne, PA
38. EARSS Annual Report 2007. Available from: http://www.rivm.nl/earss. Accessed October 29, 2009.
39. Raad II, and G.P. Bodey Infectious complications of indwelling vascular catheters Clin Infect Dis 15 1992 197 208
40. M. Al-Damouk, E. Pudney, and A. Bleetman Hand hygiene and aseptic technique in the emergency department J Hosp Infect 56 2004 137 141
41. J. Crawford, D.C. Dale, and G.H. Lyman Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management Cancer 100 2004 228 237
42. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings, June 2007. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/ isolation2007.pdf. Accessed November 26, 2009.